These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Depletion and repopulation of Langerhans cells in nonsegmental type vitiligo. Kao CH; Yu HS J Dermatol; 1990 May; 17(5):287-96. PubMed ID: 2380433 [TBL] [Abstract][Full Text] [Related]
7. Th17 cells and activated dendritic cells are increased in vitiligo lesions. Wang CQ; Cruz-Inigo AE; Fuentes-Duculan J; Moussai D; Gulati N; Sullivan-Whalen M; Gilleaudeau P; Cohen JA; Krueger JG PLoS One; 2011 Apr; 6(4):e18907. PubMed ID: 21541348 [TBL] [Abstract][Full Text] [Related]
8. Local immune response in skin of generalized vitiligo patients. Destruction of melanocytes is associated with the prominent presence of CLA+ T cells at the perilesional site. van den Wijngaard R; Wankowicz-Kalinska A; Le Poole C; Tigges B; Westerhof W; Das P Lab Invest; 2000 Aug; 80(8):1299-309. PubMed ID: 10950121 [TBL] [Abstract][Full Text] [Related]
9. Ultrastructural studies of vitiligo with inflammatory raised borders. Ishii M; Hamada T J Dermatol; 1981 Aug; 8(4):313-22. PubMed ID: 7028831 [No Abstract] [Full Text] [Related]
11. [Quantitative ultrastructural study of the epidermis basal layer in the vitiligo patches and in the marginal hyperchromic and normal skin (author's transl)]. Gonçalves RP; Bechelli LM; Trad ES; Zanin LC Ann Dermatol Venereol; 1978 Apr; 105(4):395-400. PubMed ID: 686613 [TBL] [Abstract][Full Text] [Related]
12. T-cell responses against 4-tert-butylphenol-exposed pigmented cells in a patient with occupational vitiligo. Vrijman C; Willemsen KJ; Tjin EPM; Kammeyer A; van den Boorn JG; van der Veen JPW; Jungbauer FHW; Kardaun SH; Luiten RM Br J Dermatol; 2019 Aug; 181(2):387-388. PubMed ID: 30719700 [No Abstract] [Full Text] [Related]
13. Epidermal Langerhans cells in various skin diseases. (2). Langerhans cells in vitiligo. Kano Y; Shiohara T; Nagashima M J Dermatol; 1984 Apr; 11(2):103-10. PubMed ID: 6384304 [No Abstract] [Full Text] [Related]
14. First histopathological and immunophenotypic analysis of early dynamic events in a patient with segmental vitiligo associated with halo nevi. van Geel NA; Mollet IG; De Schepper S; Tjin EP; Vermaelen K; Clark RA; Kupper TS; Luiten RM; Lambert J Pigment Cell Melanoma Res; 2010 Jun; 23(3):375-84. PubMed ID: 20370855 [TBL] [Abstract][Full Text] [Related]
15. Vitiligo as a skin memory disease: The need for early intervention with immunomodulating agents and a maintenance therapy to target resident memory T cells. Boniface K; Seneschal J Exp Dermatol; 2019 Jun; 28(6):656-661. PubMed ID: 30636075 [TBL] [Abstract][Full Text] [Related]
16. [Scanning electron microscopy in vitiligo]. Vaisov ASh; Baĭbekov IM; Khoroshaev VA Vestn Dermatol Venerol; 1987; (4):19-20. PubMed ID: 3604441 [No Abstract] [Full Text] [Related]
17. Autoimmune etiology of generalized vitiligo. Le Poole IC; Luiten RM Curr Dir Autoimmun; 2008; 10():227-43. PubMed ID: 18460889 [TBL] [Abstract][Full Text] [Related]
18. Epidermal Langerhans cells are critical for immunoregulation of cutaneous leishmaniasis. Moll H Immunol Today; 1993 Aug; 14(8):383-7. PubMed ID: 8397776 [TBL] [Abstract][Full Text] [Related]
19. Dendritic cells: ultrastructural and immunophenotypical changes upon nb-UVB in vitiligo skin. Prignano F; Ricceri F; Bianchi B; Guasti D; Bonciolini V; Lotti T; Pimpinelli N Arch Dermatol Res; 2011 May; 303(4):231-8. PubMed ID: 21174109 [TBL] [Abstract][Full Text] [Related]